Circulating Lipids Are Associated with Alcoholic Liver Cirrhosis and Represent Potential Biomarkers for Risk Assessment

• Peter J. Meikle ,

  * E-mail: peter.meikle@bakeridi.edu.au (PM); d.seth@sydney.edu.au (DS)

  Affiliation Baker IDI Heart and Diabetes Institute, Melbourne, Vic 3004, Australia

  ⨯
• Piyushkumar A. Mundra,

  Affiliation Baker IDI Heart and Diabetes Institute, Melbourne, Vic 3004, Australia

  ⨯
• Gerard Wong,

  Affiliation Baker IDI Heart and Diabetes Institute, Melbourne, Vic 3004, Australia

  ⨯
• Khairunnessa Rahman,

  Affiliation Discipline of Clinical Medicine & Addiction Medicine, Faculty of Medicine, University of Sydney, Sydney, NSW 2006, Australia

  ⨯
• Kevin Huynh,

  Affiliation Baker IDI Heart and Diabetes Institute, Melbourne, Vic 3004, Australia

  ⨯
• Christopher K. Barlow,

  Affiliation Baker IDI Heart and Diabetes Institute, Melbourne, Vic 3004, Australia

  ⨯
• Alastair M. P. Duly,

  Affiliation Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia

  ⨯
• Paul S. Haber,

  Affiliations Discipline of Clinical Medicine & Addiction Medicine, Faculty of Medicine, University of Sydney, Sydney, NSW 2006, Australia, Drug Health Services and Centenary Institute of Cancer Medicine and Cell Biology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia

  ⨯
• John B. Whitfield,

  Affiliation Genetic Epidemiology, QIMR Berghofer Medical Research Institute, Herston, Queensland 4029, Australia

  ⨯
• Devanshi Seth

  * E-mail: peter.meikle@bakeridi.edu.au (PM); d.seth@sydney.edu.au (DS)

  Affiliations Discipline of Clinical Medicine & Addiction Medicine, Faculty of Medicine, University of Sydney, Sydney, NSW 2006, Australia, Drug Health Services and Centenary Institute of Cancer Medicine and Cell Biology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia

  ⨯